Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 32,387 articles published since 2008
|||| 50 

These are the 32387 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
176 Editorial MYCN-mediated murine cancer models. 2017

Althoff, Kristina / Schramm, Alexander. ·Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. ·Aging (Albany NY) · Pubmed #28377536.

ABSTRACT: -- No abstract --

177 Editorial Pancreatic Cancer: Challenge and Inspiration. 2017

Bates, Susan E. ·Columbia University Medical Center. ·Clin Cancer Res · Pubmed #28373360.

ABSTRACT: -- No abstract --

178 Editorial The role of γδ T cells in pancreatic cancer: what could this mean for the clinic? 2017

Daley, Donnele / Miller, George. ·a S. Arthur Localio Laboratory, Department of Surgery , New York University School of Medicine , New York , NY , USA. · b S. Arthur Localio Laboratory, Department of Cell Biology , New York University School of Medicine , New York , NY , USA. ·Expert Rev Gastroenterol Hepatol · Pubmed #28345379.

ABSTRACT: -- No abstract --

179 Editorial Loss of a primary cilium in PDAC. 2017

Kobayashi, Tetsuo / Itoh, Hiroshi. ·a Graduate School of Biological Sciences , Nara Institute of Science and Technology , Takayama, Ikoma , Nara , Japan. ·Cell Cycle · Pubmed #28319439.

ABSTRACT: -- No abstract --

180 Editorial The Countdown to a Paradigm Shift in Diagnosing Pancreatic Ductal Adenocarcinoma. 2017

Coté, Gregory A. ·Division of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina. ·Clin Gastroenterol Hepatol · Pubmed #28300695.

ABSTRACT: -- No abstract --

181 Editorial Pancreatic ductal adenocarcinoma: is a cure possible? 2017

Ansari, Daniel / Andersson, Roland. ·Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden. ·Future Oncol · Pubmed #28266248.

ABSTRACT: -- No abstract --

182 Editorial Private Funding for Pancreatic Cancer Research: More Than a Chip Shot. 2017

Hendifar, Andrew E / Davies, Lynne / Tuli, Richard. ·Cedars-Sinai Medical Center, Los Angeles, California. · International Cancer Research Partnership, London, United Kingdom. ·Gastroenterology · Pubmed #28259790.

ABSTRACT: -- No abstract --

183 Editorial Pancreaticoduodenectomy for pancreatic cancer: perspective from the United States. 2017

Ejaz, Aslam / He, Jin. ·Department of Surgery, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Department of Surgery, the Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. jhe11@jhmi.edu. ·Chin Clin Oncol · Pubmed #28249540.

ABSTRACT: -- No abstract --

184 Editorial PD-L1 Expression in Pancreatic Cancer. 2017

Zheng, Lei. ·Affiliations of authors: Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Graduate Program in Cellular and Molecular Medicine, Department of Surgery, The Skip Viragh Center for Pancreatic Cancer, and The Bloomberg-Kimmel Institute of Cancer Immunotherapy, The Johns Hopkins University School of Medicine, Baltimore, MD. ·J Natl Cancer Inst · Pubmed #28131993.

ABSTRACT: -- No abstract --

185 Editorial Presence of small pancreatic cystic lesions should not preclude liver transplantation. 2017

Barkin, Jodie A / Barkin, Jamie S. ·Division of Gastroenterology, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, FL. ·Liver Transpl · Pubmed #28103652.

ABSTRACT: -- No abstract --

186 Editorial CXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy? 2017

Morton, Jennifer P / Sansom, Owen J. ·Cancer Research UK Beatson Institute, Switchback Rd, Glasgow, G61 1BD, UK. · Institute of Cancer Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK. ·Immunotherapy · Pubmed #28000523.

ABSTRACT: -- No abstract --

187 Editorial What's in a Name? Steady Progress in Staging Pancreatic Neuroendocrine Tumors. 2017

Halperin, Daniel M / Yao, James C / Dasari, Arvind. ·Daniel M. Halperin, James C. Yao, and Arvind Dasari, MD Anderson Cancer Center, Houston, TX. ·J Clin Oncol · Pubmed #27893328.

ABSTRACT: -- No abstract --

188 Editorial Epigenomic therapies: the potential of targeting SIRT6 for the treatment of pancreatic cancer. 2017

Demir, Ihsan Ekin / Ceyhan, Güralp O / Friess, Helmut. ·a Department of Surgery, Klinikum rechts der Isar , Technische Universität München , Munich , Germany. ·Expert Opin Ther Targets · Pubmed #27885875.

ABSTRACT: -- No abstract --

189 Editorial Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma? 2017

Kourie, Hampig Raphael / Gharios, Joseph / Kattan, Joseph. ·Oncology Department, Jules Bordet Institute, Brussels, Belgium. · Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. · General Surgery Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. ·Future Oncol · Pubmed #27624286.

ABSTRACT: -- No abstract --

190 Editorial Percutaneous ablation of pancreatic cancer. 2016

D'Onofrio, Mirko / Ciaravino, Valentina / De Robertis, Riccardo / Barbi, Emilio / Salvia, Roberto / Girelli, Roberto / Paiella, Salvatore / Gasparini, Camilla / Cardobi, Nicolò / Bassi, Claudio. ·Mirko D'Onofrio, Valentina Ciaravino, Riccardo De Robertis, Camilla Gasparini, Nicolò Cardobi, Department of Radiology, G.B. Rossi Hospital, University of Verona, 37134 Verona, Italy. ·World J Gastroenterol · Pubmed #27956791.

ABSTRACT: Pancreatic ductal adenocarcinoma is a highly aggressive tumor with an overall 5-year survival rate of less than 5%. Prognosis and treatment depend on whether the tumor is resectable or not, which mostly depends on how quickly the diagnosis is made. Chemotherapy and radiotherapy can be both used in cases of non-resectable pancreatic cancer. In cases of pancreatic neoplasm that is locally advanced, non-resectable, but non-metastatic, it is possible to apply percutaneous treatments that are able to induce tumor cytoreduction. The aim of this article will be to describe the multiple currently available treatment techniques (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation), their results, and their possible complications, with the aid of a literature review.

191 Editorial Special issue editorial-Cancer Genetics. 2016

Rosemurgy, Alexander. · ·Cancer Genet · Pubmed #27931696.

ABSTRACT: -- No abstract --

192 Editorial Thinking the unthinkable. 2016

Srinivasa, Sanket / Koea, Jonathan B. ·Upper Gastrointestinal Unit, Department of Surgery, North Shore Hospital, Auckland, New Zealand. ·ANZ J Surg · Pubmed #27910269.

ABSTRACT: -- No abstract --

193 Editorial Preface. 2016

Hardacre, Jeffrey M. ·Associate Professor of Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA. Electronic address: jeffrey.hardacre@uhhospitals.org. ·Surg Clin North Am · Pubmed #27865289.

ABSTRACT: -- No abstract --

194 Editorial Early and accurate diagnosis of pancreatic cancer? 2016

Sharib, Jeremy / Kirkwood, Kimberly. · ·Oncotarget · Pubmed #27829239.

ABSTRACT: -- No abstract --

195 Editorial Translational Diagnostics and Therapeutics in Pancreatic Neuroendocrine Tumors. 2016

Maxwell, Jessica E / Sherman, Scott K / Howe, James R. ·Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa. · Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa. james-howe@uiowa.edu. ·Clin Cancer Res · Pubmed #27742788.

ABSTRACT: Pancreatic neuroendocrine tumors (PNET) are rare tumors, but have been increasing in incidence. Although typically thought of as indolent, more than half of patients present with metastatic disease. For many years, the only mutations commonly known in these tumors were those in the MEN1 gene. Recently, the genetics underlying PNETs have been further defined through exome sequencing. The most frequent alterations found in sporadic PNETs are in MEN1, DAXX/ATRX, and a variety of genes in the mTOR pathway. Confirmation of these mutations has prompted trials with a number of drugs active in these pathways, and two drugs were eventually approved in 2011-sunitinib and everolimus. New data additionally identify the MET and CD47 receptors as potential novel drug targets. Yet despite improvements in progression-free survival with sunitinib and everolimus, further studies defining when to use these agents and factors associated with limitations in their utility are needed. As more discoveries are made in the laboratory that elucidate additional molecular mechanisms important in the initiation and metastasis of PNETs, continued efforts to translate these discoveries into distinct new therapies will be needed to improve patient survival. Clin Cancer Res; 22(20); 5022-9. ©2016 AACR SEE ALL ARTICLES IN THIS CCR FOCUS SECTION, "ENDOCRINE CANCERS REVISING PARADIGMS".

196 Editorial EUS-guided FNA for diagnosing autoimmune pancreatitis: Does it enhance existing consensus criteria? 2016

Majumder, Shounak / Chari, Suresh T. ·Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA. ·Gastrointest Endosc · Pubmed #27742043.

ABSTRACT: -- No abstract --

197 Editorial Repeated pancreatic cyst sampling for carcinoembryonic antigen analysis: Is it worth another poke? 2016

Al-Haddad, Mohammad. ·Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. ·Gastrointest Endosc · Pubmed #27742041.

ABSTRACT: -- No abstract --

198 Editorial TIMPing Fate: Why Pancreatic Cancer Cells Sojourn in the Liver. 2016

Torres-Hernandez, Alejandro / Miller, George. ·S. Arthur Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, New York. Electronic address: Alejandro.Torres-Hernandez@med.nyu.edu. · Departments of Surgery and Cell Biology, New York University School of Medicine, New York, New York. ·Gastroenterology · Pubmed #27702557.

ABSTRACT: -- No abstract --

199 Editorial Investigational histone deacetylase inhibitors for treating pancreatic adenocarcinoma. 2016

Arlt, Alexander / Schäfer, Heiner. ·a Department of Internal Medicine I , Laboratory for Gastrointestinal Signal Transduction, UKSH Campus Kiel , Kiel , Germany. · b Institute for Experimental Cancer Research , Laboratory of Molecular Gastroenterology, - Christian-Albrechts-University & UKSH Campus Kiel , Kiel , Germany. ·Expert Opin Investig Drugs · Pubmed #27666721.

ABSTRACT: -- No abstract --

200 Editorial Wanted: improved diagnostic accuracy or tissue for histology by EUS-FNA. Do side-holes do the job? 2016

Karstensen, John Gásdal / Vilmann, Peter. ·Gastro Unit, Division of Endoscopy, Copenhagen University Hospital, Herlev, Denmark; Gastro Unit, Division of Surgery, Copenhagen University Hospital, Hvidovre, Denmark. · Gastro Unit, Division of Endoscopy, Copenhagen University Hospital, Herlev, Denmark. ·Gastrointest Endosc · Pubmed #27633361.

ABSTRACT: -- No abstract --

Back · Next